Toward prediction and control of antibiotic-resistance evolution

Current Opinion in Biotechnology

Volumn 54, Issue , 2018, Pages 45-49

  Furusawa, Chikara ^a,b   Horinouchi, Takaaki ^a   Maeda, Tomoya ^a  

^a RIKEN Center for Biosystems Dynamics Research   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; CONTROLLED DRUG DELIVERY;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC-RESISTANT BACTERIA; DRUG RESISTANCE; EVOLUTIONARY BIOLOGY; GENOTYPIC CHANGE; PREDICTION AND CONTROL; PUBLIC CONCERN;

BIOLOGY;

ANTIBIOTIC AGENT; CHLORAMPHENICOL; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; CONTROLLED STUDY; ESCHERICHIA COLI; EVOLUTION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HIGH THROUGHPUT SEQUENCING; HORIZONTAL GENE TRANSFER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; DIRECTED MOLECULAR EVOLUTION; MOLECULAR EVOLUTION;

DIRECTED MOLECULAR EVOLUTION; DRUG RESISTANCE, MICROBIAL; EVOLUTION, MOLECULAR;

EID: 85041924132     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2018.01.026     Document Type: Review

References (54)

1. Watkins, R.R., Bonomo, R.A., Overview: global and local impact of antibiotic resistance. Infect Dis Clin North Am 30 (2016), 313–322.
2. Leibovici, L., Paul, M., Garner, P., Sinclair, D.J., Afshari, A., Pace, N.L., Cullum, N., Williams, H.C., Smyth, A., Skoetz, N., et al. Addressing resistance to antibiotics in systematic reviews of antibiotic interventions. J Antimicrob Chemother 71 (2016), 2367–2369.
3. Hughes, D., Andersson, D.I., Evolutionary trajectories to antibiotic resistance. Annu Rev Microbiol 71 (2017), 579–596.
4. Banin, E., Hughes, D., Kuipers, O.P., Editorial: bacterial pathogens, antibiotics and antibiotic resistance. FEMS Microbiol Rev 41 (2017), 450–452.
5. Martínez, J.L., Antibiotics and antibiotic resistance genes in natural environments. Science 321 (2008), 365–367.
6. Davies, J., Davies, D., Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 74 (2010), 417–433.
7. von Wintersdorff, C.J.H., Penders, J., van Niekerk, J.M., Mills, N.D., Majumder, S., van Alphen, L.B., Savelkoul, P.H.M., Wolffs, P.F.G., Dissemination of antimicrobial resistance in microbial ecosystems through horizontal gene transfer. Front Microbiol, 7, 2016, 173.
8. Toprak, E., Veres, A., Michel, J.-B., Chait, R., Hartl, D.L., Kishony, R., Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat Genet 44 (2012), 101–105.
9. Ashton, P.M., Nair, S., Dallman, T., Rubino, S., Rabsch, W., Mwaigwisya, S., Wain, J., O'Grady, J., MinION nanopore sequencing identifies the position and structure of a bacterial antibiotic resistance island. Nat Biotechnol 33 (2014), 296–300.
10. Lukačišinová, M., Bollenbach, T., Toward a quantitative understanding of antibiotic resistance evolution. Curr Opin Biotechnol 46 (2017), 90–97.
11. Andersson, D.I., Hughes, D., Antibiotic resistance and its cost: is it possible to reverse resistance?. Nat Rev Microbiol, 8, 2010, 260.
12. Borrell, S., Trauner, A., Strain Diversity and the Evolution of Antibiotic Resistance. 2017, Springer, 263–279.
13. Weinreich, D.M., Watson, R.A., Chao, L., Perspective: sign epistasis and genetic constraint on evolutionary trajectories. Evolution (N Y), 59, 2005, 1165.
14. Kryazhimskiy, S., Rice, D.P., Jerison, E.R., Desai, M.M., Global epistasis makes adaptation predictable despite sequence-level stochasticity. Science (80-), 2014, 344.
15. Lässig, M., Mustonen, V., Walczak, A.M., Predicting evolution. Nat Ecol Evol, 1, 2017, 77.
16. Palmer, A.C., Kishony, R., Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance. Nat Rev Genet 14 (2013), 243–248.
17. de Visser, J.A.G.M., Krug, J., Empirical fitness landscapes and the predictability of evolution. Nat Rev Genet 15 (2014), 480–490.
18. Conrad, T.M., Lewis, N.E., Palsson, B.Ø., Albert, T., Dailidiene, D., Dailide, G., Norton, J., Kalia, A., Richmond, T., Molla, M., et al. Microbial laboratory evolution in the era of genome-scale science. Mol Syst Biol, 7, 2011, 509.
19. Lenski, R.E., Experimental evolution and the dynamics of adaptation and genome evolution in microbial populations. ISME J 11 (2017), 2181–2194.
20. Barrick, J.E., Yu, D.S., Yoon, S.H., Jeong, H., Oh, T.K., Schneider, D., Lenski, R.E., Kim, J.F., Genome evolution and adaptation in a long-term experiment with Escherichia coli. Nature 461 (2009), 1243–1247.
21. Maddamsetti, R., Lenski, R.E., Barrick, J.E., Adaptation, clonal interference, and frequency-dependent interactions in a long-term evolution experiment with Escherichia coli. Genetics 200 (2015), 619–631.
22. Good, B.H., McDonald, M.J., Barrick, J.E., Lenski, R.E., Desai, M.M., The dynamics of molecular evolution over 60,000 generations. Nature 551 (2017), 45–50 This study is a recent analysis of long-term laboratory evolution of E. coli by Lenski and colleagues. The coexistence of multiple sub-populations is demonstrated, indicating an important role for ecological interactions among them. Epistatic interactions and historical contingencies among mutations are also discussed.
23. Imamovic, L., Sommer, M.O.A., Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Sci Transl Med, 5, 2013 204ra132.
24. Zampieri, M., Enke, T., Chubukov, V., Ricci, V., Piddock, L., Sauer, U., Metabolic constraints on the evolution of antibiotic resistance. Mol Syst Biol, 13, 2017, 917 This study demonstrates the interaction between the metabolic state and antibiotic-resistant evolution. Understanding the metabolic constraints will contribute to rational strategies for controlling the evolution of antibiotic resistance evolution.
25. Yen, P., Papin, J.A., History of antibiotic adaptation influences microbial evolutionary dynamics during subsequent treatment. PLOS Biol, 15, 2017, e2001586.
26. Toprak, E., Veres, A., Yildiz, S., Pedraza, J.M., Chait, R., Paulsson, J., Kishony, R., Building a morbidostat: an automated continuous-culture device for studying bacterial drug resistance under dynamically sustained drug inhibition. Nat Protoc 8 (2013), 555–567.
27. Zhang, Q., Lambert, G., Liao, D., Kim, H., Robin, K., Tung, C., Pourmand, N., Austin, R.H., Acceleration of emergence of bacterial antibiotic resistance in connected microenvironments. Science 333 (2011), 1764–1767.
28. Baym, M., Lieberman, T.D., Kelsic, E.D., Chait, R., Gross, R., Yelin, I., Kishony, R., Spatiotemporal microbial evolution on antibiotic landscapes. Science 353 (2016), 1147–1151 This is the first study to show a spatiotemporal pattern of evolutionary dynamics on an agar plate. The authors prepared a huge agar plate with a drug-concentration gradient, on which mutation and selection to antibiotic resistance were visualized in a migrating bacterial front.
29. Lang, G.I., Rice, D.P., Hickman, M.J., Sodergren, E., Weinstock, G.M., Botstein, D., Desai, M.M., Pervasive genetic hitchhiking and clonal interference in forty evolving yeast populations. Nature 500 (2013), 571–574.
30. Papp, B., Notebaart, R.A., Pál, C., Systems-biology approaches for predicting genomic evolution. Nat Rev Genet 12 (2011), 591–602.
31. Sommer, M.O.A., Munck, C., Toft-Kehler, R.V., Andersson, D.I., Prediction of antibiotic resistance: time for a new preclinical paradigm?. Nat Rev Microbiol 15 (2017), 689–696.
32. Lobkovsky, A.E., Koonin, E.V., Replaying the tape of life: quantification of the predictability of evolution. Front Genet, 3, 2012, 246.
33. Miton, C.M., Tokuriki, N., How mutational epistasis impairs predictability in protein evolution and design. Protein Sci 25 (2016), 1260–1272.
34. Bush, K., Jacoby, G.A., Medeiros, A.A., A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 39 (1995), 1211–1233.
35. Schenk, M.F., Szendro, I.G., Salverda, M.L.M., Krug, J., de Visser, J.A.G.M., Patterns of epistasis between beneficial mutations in an antibiotic resistance gene. Mol Biol Evol 30 (2013), 1779–1787.
36. Weinreich, D.M., Delaney, N.F., Depristo, M.A., Hartl, D.L., Robin, K., Tung, C., Pourmand, N., Austin, R.H., Darwinian evolution can follow only very few mutational paths to fitter proteins. Science 312 (2006), 111–114.
37. Jacquier, H., Birgy, A., Le Nagard, H., Mechulam, Y., Schmitt, E., Glodt, J., Bercot, B., Petit, E., Poulain, J., Barnaud, G., et al. Capturing the mutational landscape of the beta-lactamase TEM-1. Proc Natl Acad Sci U S A 110 (2013), 13067–13072.
38. Schenk, M.F., Szendro, I.G., Krug, J., de Visser, J.A.G.M., Quantifying the adaptive potential of an antibiotic resistance enzyme. PLoS Genet, 8, 2012, e1002783.
39. Firnberg, E., Labonte, J.W., Gray, J.J., Ostermeier, M., A comprehensive, high-resolution map of a gene's fitness landscape. Mol Biol Evol 31 (2014), 1581–1592.
40. Lázár, V., Pal Singh, G., Spohn, R., Nagy, I., Horváth, B., Hrtyan, M., Busa-Fekete, R., Bogos, B., Méhi, O., Csörgő, B., et al. Bacterial evolution of antibiotic hypersensitivity. Mol Syst Biol, 9, 2013, 700.
41. Suzuki, S., Horinouchi, T., Furusawa, C., Prediction of antibiotic resistance by gene expression profiles. Nat Commun, 2014, 5.
42. Stolovicki, E., Dror, T., Brenner, N., Braun, E., Synthetic gene recruitment reveals adaptive reprogramming of gene regulation in yeast. Genetics 173 (2006), 75–85.
43. Keren, L., Zackay, O., Lotan-Pompan, M., Barenholz, U., Dekel, E., Sasson, V., Aidelberg, G., Bren, A., Zeevi, D., Weinberger, A., et al. Promoters maintain their relative activity levels under different growth conditions. Mol Syst Biol, 9, 2013, 701.
44. Kaneko, K., Furusawa, C., Yomo, T., Universal relationship in gene-expression changes for cells in steady-growth state. Phys Rev X, 5, 2015, 11014.
45. Furusawa, C., Kaneko, K., Formation of Dominant Mode by Evolution in Biological Systems. 2017.
46. Baym, M., Stone, L.K., Kishony, R., Multidrug evolutionary strategies to reverse antibiotic resistance. Science, 351, 2016 aad3292.
47. Imamovic, L., Sommer, M.O.A., Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Sci Transl Med, 5, 2013 204ra132-204ra132.
48. Rodriguez de Evgrafov, M., Gumpert, H., Munck, C., Thomsen, T.T., Sommer, M.O.A., Collateral resistance and sensitivity modulate evolution of high-level resistance to drug combination treatment in Staphylococcus aureus. Mol Biol Evol 32 (2015), 1175–1185.
49. Suzuki, S., Horinouchi, T., Furusawa, C., Acceleration and suppression of resistance development by antibiotic combinations. BMC Genomics, 2017, 18.
50. Brown, E.M., Nathwani, D., Antibiotic cycling or rotation: a systematic review of the evidence of efficacy. J Antimicrob Chemother 55 (2005), 6–9.
51. Yoshida, M., Reyes, S.G., Tsuda, S., Horinouchi, T., Furusawa, C., Cronin, L., Time-programmable drug dosing allows the manipulation, suppression and reversal of antibiotic drug resistance in vitro. Nat Commun, 8, 2017, 15589 This study demonstrated that drug resistance evolution can be manipulated by dynamically changing the drug dosage. Using a morbidostat culture system, they show that a switching between certain combinations of drugs can suppress the evolution of antibiotic resistance. Furthermore, a simple mathematical model was developed that allows for the prediction of the development of resistance under modulating antibiotic concentrations.
52. Tenaillon, O., Rodríguez-Verdugo, A., Gaut, R.L., McDonald, P., Bennett, A.F., Long, A.D., Gaut, B.S., Silander, O.K., Tenaillon, O., Chao, L., et al. The molecular diversity of adaptive convergence. Science 335 (2012), 457–461.
53. Karr, J.R., Takahashi, K., Funahashi, A., The principles of whole-cell modeling. Curr Opin Microbiol 27 (2015), 18–24 This review discusses an importance of whole-cell modeling of organisms, which involves various cellular functions as genome replication, transcription, translation, and metabolism. This approach might contribute to predicting and control of resistant evolution.
54. Angermueller, C., Pärnamaa, T., Parts, L., Stegle, O., Deep learning for computational biology. Mol Syst Biol, 12, 2016, 878.